Central Pacific Bank Trust Division Lowers Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Central Pacific Bank Trust Division trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 27.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,665 shares of the healthcare conglomerate’s stock after selling 1,359 shares during the quarter. Central Pacific Bank Trust Division’s holdings in UnitedHealth Group were worth $1,854,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of UNH. GPM Growth Investors Inc. bought a new stake in shares of UnitedHealth Group in the 2nd quarter worth about $6,395,000. Stablepoint Partners LLC boosted its holdings in shares of UnitedHealth Group by 8.5% in the 2nd quarter. Stablepoint Partners LLC now owns 5,401 shares of the healthcare conglomerate’s stock worth $2,751,000 after purchasing an additional 424 shares during the period. Mattern Capital Management LLC lifted its position in UnitedHealth Group by 0.4% in the second quarter. Mattern Capital Management LLC now owns 19,007 shares of the healthcare conglomerate’s stock worth $9,680,000 after buying an additional 77 shares during the last quarter. Arbor Trust Wealth Advisors LLC raised its stake in shares of UnitedHealth Group by 5.9% in the second quarter. Arbor Trust Wealth Advisors LLC now owns 2,713 shares of the healthcare conglomerate’s stock valued at $1,382,000 after acquiring an additional 150 shares during the period. Finally, Commons Capital LLC boosted its stake in shares of UnitedHealth Group by 4.5% during the 2nd quarter. Commons Capital LLC now owns 3,770 shares of the healthcare conglomerate’s stock worth $1,920,000 after purchasing an additional 163 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UNH stock traded up $9.74 during trading hours on Friday, hitting $514.25. 1,511,461 shares of the stock traded hands, compared to its average volume of 2,838,250. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market cap of $473.26 billion, a P/E ratio of 33.50, a P/E/G ratio of 1.53 and a beta of 0.58. The stock has a 50-day simple moving average of $560.86 and a 200 day simple moving average of $560.03.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same period last year, the company posted $6.56 EPS. The company’s revenue was up 9.2% compared to the same quarter last year. Equities analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.63%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Analysts Set New Price Targets

UNH has been the topic of a number of research analyst reports. Oppenheimer upped their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. TD Cowen increased their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Piper Sandler reduced their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday. Stephens upped their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Finally, Truist Financial reiterated a “buy” rating and set a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Three analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average target price of $628.37.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.